Attached files
file | filename |
---|---|
8-K - FORM 8-K - KFORCE INC | d330405d8k.htm |
Exhibit 99.1
KFORCE INC. AND SUBSIDIARIES
UNAUDITED PRO FORMA CONDENSED CONSOLIDATED
STATEMENTS OF OPERATIONS
FOR THE YEAR ENDED DECEMBER 31, 2011
(IN THOUSANDS, EXCEPT PER SHARE AMOUNTS)
Historical | Pro Forma Adjustments |
Pro Forma | ||||||||||
Net service revenues |
$ | 1,110,919 | $ | 106,172 | (a) | $ | 1,004,747 | |||||
Direct costs of services |
764,616 | 77,616 | (a) | 687,000 | ||||||||
|
|
|
|
|
|
|||||||
Gross profit |
346,303 | 28,556 | 317,747 | |||||||||
Selling, general and administrative expenses |
288,981 | 14,909 | (b) | 274,072 | ||||||||
Depreciation and amortization |
12,694 | 189 | (c) | 12,505 | ||||||||
|
|
|
|
|
|
|||||||
Income from continuing operations |
44,628 | 13,458 | 31,170 | |||||||||
Other expense (income): |
||||||||||||
Interest expense |
1,256 | 60 | (d) | 1,196 | ||||||||
Other expense (income) |
61 | 0 | 61 | |||||||||
|
|
|
|
|
|
|||||||
Income from continuing operations before income taxes |
43,311 | 13,398 | 29,913 | |||||||||
Income tax expense |
16,155 | 5,298 | (e) | 10,857 | ||||||||
|
|
|
|
|
|
|||||||
Net income from continuing operations |
$ | 27,156 | $ | 8,100 | $ | 19,056 | ||||||
|
|
|
|
|
|
|||||||
Earnings per share basic |
||||||||||||
From continuing operations |
$ | 0.72 | $ | 0.22 | $ | 0.50 | ||||||
Earnings per share diluted |
||||||||||||
From continuing operations |
$ | 0.70 | $ | 0.21 | $ | 0.49 | ||||||
Weighted average shares outstanding basic |
37,835 | 37,835 | 37,835 | |||||||||
Weighted average shares outstanding diluted |
38,831 | 38,831 | 38,831 |
See the accompanying notes to the unaudited pro forma condensed consolidated financial statements.
KFORCE INC. AND SUBSIDIARIES
UNAUDITED PRO FORMA CONDENSED CONSOLIDATED
STATEMENTS OF OPERATIONS
FOR THE YEAR ENDED DECEMBER 31, 2010
(IN THOUSANDS, EXCEPT PER SHARE AMOUNTS)
Historical | Pro Forma Adjustments |
Pro Forma | ||||||||||
Net service revenues |
$ | 990,807 | $ | 104,150 | (a) | $ | 886,657 | |||||
Direct costs of services |
678,393 | 75,582 | (a) | 602,811 | ||||||||
|
|
|
|
|
|
|||||||
Gross profit |
312,414 | 28,568 | 283,846 | |||||||||
Selling, general and administrative expenses |
265,183 | 14,027 | (b) | 251,156 | ||||||||
Depreciation and amortization |
12,611 | 22 | (c) | 12,589 | ||||||||
|
|
|
|
|
|
|||||||
Income from continuing operations |
34,620 | 14,519 | 20,101 | |||||||||
Other expense (income): |
||||||||||||
Interest expense |
1,274 | 60 | (d) | 1,214 | ||||||||
Other expense (income) |
22 | 0 | 22 | |||||||||
|
|
|
|
|
|
|||||||
Income from continuing operations before income taxes |
33,324 | 14,459 | 18,865 | |||||||||
Income tax expense |
12,690 | 5,821 | (e) | 6,869 | ||||||||
|
|
|
|
|
|
|||||||
Net income from continuing operations |
$ | 20,634 | $ | 8,638 | $ | 11,996 | ||||||
|
|
|
|
|
|
|||||||
Earnings per share basic |
||||||||||||
From continuing operations |
$ | 0.52 | $ | 0.22 | $ | 0.30 | ||||||
Earnings per share diluted |
||||||||||||
From continuing operations |
$ | 0.51 | $ | 0.21 | $ | 0.30 | ||||||
Weighted average shares outstanding basic |
39,480 | 39,480 | 39,480 | |||||||||
Weighted average shares outstanding diluted |
40,503 | 40,503 | 40,503 |
See the accompanying notes to the unaudited pro forma condensed consolidated financial statements.
KFORCE INC. AND SUBSIDIARIES
UNAUDITED PRO FORMA CONDENSED CONSOLIDATED
STATEMENTS OF OPERATIONS
FOR THE YEAR ENDED DECEMBER 31, 2009
(IN THOUSANDS, EXCEPT PER SHARE AMOUNTS)
Historical | Pro Forma Adjustments |
Pro Forma | ||||||||||
Net service revenues |
$ | 910,136 | $ | 108,028 | (a) | $ | 802,108 | |||||
Direct costs of services |
624,157 | 79,279 | (a) | 544,878 | ||||||||
|
|
|
|
|
|
|||||||
Gross profit |
285,979 | 28,749 | 257,230 | |||||||||
Selling, general and administrative expenses |
251,268 | 12,903 | (b) | 238,365 | ||||||||
Depreciation and amortization |
11,673 | 0 | (c) | 11,673 | ||||||||
|
|
|
|
|
|
|||||||
Income from continuing operations |
23,038 | 15,846 | 7,192 | |||||||||
Other expense (income): |
||||||||||||
Interest expense |
1,437 | 60 | (d) | 1,377 | ||||||||
Other expense (income) |
(292 | ) | 0 | (292 | ) | |||||||
|
|
|
|
|
|
|||||||
Income from continuing operations before income taxes |
21,893 | 15,786 | 6,107 | |||||||||
Income tax expense |
9,020 | 6,336 | (e) | 2,684 | ||||||||
|
|
|
|
|
|
|||||||
Net income from continuing operations |
$ | 12,873 | $ | 9,450 | $ | 3,423 | ||||||
|
|
|
|
|
|
|||||||
Earnings per share basic |
||||||||||||
From continuing operations |
$ | 0.33 | $ | 0.24 | $ | 0.09 | ||||||
Earnings per share diluted |
||||||||||||
From continuing operations |
$ | 0.33 | $ | 0.24 | $ | 0.09 | ||||||
Weighted average shares outstanding basic |
38,485 | 38,485 | 38,485 | |||||||||
Weighted average shares outstanding diluted |
39,330 | 39,330 | 39,330 |
See the accompanying notes to the unaudited pro forma condensed consolidated financial statements.
KFORCE INC. AND SUBSIDIARIES
UNAUDITED PRO FORMA CONDENSED CONSOLIDATED
BALANCE SHEET AS OF DECEMBER 31, 2011
(IN THOUSANDS)
Historical | Pro Forma Adjustments |
Pro Forma | ||||||||||
ASSETS | ||||||||||||
Current Assets: |
||||||||||||
Cash and cash equivalents |
$ | 939 | $ | (3 | ) (f) | $ | 936 | |||||
Trade receivables, net of allowance of $2,457 |
174,764 | (13,692 | ) (f) | 161,072 | ||||||||
Income tax refund receivable |
250 | | 250 | |||||||||
Deferred tax assets, net |
4,694 | | 4,694 | |||||||||
Prepaid expenses and other current assets |
5,592 | (449 | ) (f) | 5,143 | ||||||||
|
|
|
|
|
|
|||||||
Total current assets |
186,239 | (14,144 | ) | 172,095 | ||||||||
Fixed assets, net |
36,124 | | 36,124 | |||||||||
Other assets, net |
32,554 | (885 | ) (f) | 31,669 | ||||||||
Deferred tax assets, net |
10,042 | | 10,042 | |||||||||
Intangible assets, net |
6,635 | | 6,635 | |||||||||
Goodwill |
138,078 | (5,474 | ) (g) | 132,604 | ||||||||
|
|
|
|
|
|
|||||||
Total assets |
$ | 409,672 | (20,503 | ) | 389,169 | |||||||
|
|
|
|
|
|
|||||||
LIABILITIES AND STOCKHOLDERS EQUITY |
||||||||||||
Current Liabilities: |
||||||||||||
Accounts payable and other accrued liabilities |
$ | 26,314 | (862 | ) (f) | 25,452 | |||||||
Accrued payroll costs |
55,151 | (4,698 | ) (f) | 50,453 | ||||||||
Other current liabilities |
1,463 | | 1,463 | |||||||||
Income taxes payable |
236 | | 236 | |||||||||
|
|
|
|
|
|
|||||||
Total current liabilities |
83,164 | (5,560 | ) | 77,604 | ||||||||
Long-term debt credit facility |
49,526 | (35,049 | ) (h) | 14,477 | ||||||||
Long-term debt other |
1,609 | | 1,609 | |||||||||
Other long-term liabilities |
42,258 | | 42,258 | |||||||||
|
|
|
|
|
|
|||||||
Total liabilities |
176,557 | (40,609 | ) | 135,948 | ||||||||
|
|
|
|
|
|
|||||||
Commitments and contingencies |
||||||||||||
Stockholders Equity: |
||||||||||||
Preferred stock, $0.01 par; 15,000 shares authorized, none issued and outstanding |
| | | |||||||||
Common stock, $0.01 par; 250,000 shares authorized, 68,566 and 66,542 issued, respectively |
686 | | 686 | |||||||||
Additional paid-in capital |
372,212 | | 372,212 | |||||||||
Accumulated other comprehensive loss |
(4,050 | ) | | (4,050 | ) | |||||||
Retained earnings |
89,135 | 20,106 | (i) | 109,241 | ||||||||
Treasury stock, at cost; 30,644 and 24,823 shares, respectively |
(224,868 | ) | | (224,868 | ) | |||||||
|
|
|
|
|
|
|||||||
Total stockholders equity |
233,115 | 20,106 | 253,221 | |||||||||
|
|
|
|
|
|
|||||||
Total liabilities and stockholders equity |
$ | 409,672 | (20,503 | ) | 389,169 | |||||||
|
|
|
|
|
|
See the accompanying notes to the unaudited pro forma condensed consolidated financial statements.
KFORCE INC. AND SUBSIDIARIES
NOTES TO UNAUDITED PRO FORMA CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(IN THOUSANDS)
(a) | This adjustment reflects the elimination of the revenues and cost of services of Kforce Clinical Research, Inc. (KCR) sold to inVentiv Health, Inc. |
(b) | This adjustment reflects the elimination of the selling, general and administrative expenses of KCR, inclusive of certain reasonable allocations of costs incurred by Kforce Inc. and its subsidiaries that are necessary for and associated with revenue producing activities of KCR. This adjustment does not reflect any general corporate overhead costs. |
(c) | This adjustment represents the elimination of amortization expense attributable to capitalized software development costs related to the clinical monitoring management solution for KCR, which was sold to inVentiv Health, Inc. |
(d) | This adjustment represents an elimination of interest expense based on the proportion of assets sold to the total assets of Kforce Inc. and its subsidiaries. |
(e) | This adjustment represents the estimated income tax effect of the pro forma adjustments. The tax effect of the pro forma adjustments was calculated using the historical statutory rates in the U.S. and any permanent differences attributable to KCR for the periods presented. |
(f) | This adjustment reflects the elimination of assets and liabilities attributable to the disposition. |
(g) | This adjustment reflects the elimination of the amount of goodwill allocated to KCR. |
(h) | This adjustment reflects the receipt of the proceeds of $50,000, less transaction costs of approximately $2,470, including legal, advisory and other professional fees and transaction bonuses, less estimated taxes on the disposition of KCR of $16,065, plus the estimated excess of the working capital of KCR over the working capital requirement in the Stock Purchase Agreement as of December 31, 2011 of $3,584. The net proceeds on the disposition of KCR reduced outstanding borrowings under our Credit Facility. |
In connection with the disposition of KCR, Kforce Inc.s Board of Directors exercised its discretion to accelerate the vesting of all outstanding and unvested restricted stock awards and alternative long-term incentive awards (ALTI) effective March 30, 2012 for tax planning purposes. Kforce Inc. will recognize a tax benefit from the acceleration of the vesting of restricted stock and ALTI, which will allow it to defer all of the tax liability generated from the sale of KCR. However, no adjustment was made for this tax deduction in the unaudited pro forma condensed consolidated balance sheet.
(i) | This adjustment reflects the estimated gain of approximately $36,171 arising from the transaction, net of taxes of $16,065. The estimated gain has not been reflected in the pro forma consolidated statements of operations as it is considered to be nonrecurring in nature. No adjustment has been made to the sale proceeds to give effect to any potential post-closing adjustments under the terms of the Stock Purchase Agreement. |